Erenumab for preventing migraine

12th April 2021 by Dr Louise Hudman

Erenumab for preventing migraine

This is a new guideline from NICE advising that erenumab can be used for the prevention of migraine, published in March.

I did a blog a couple of months ago on galcanezumab, which was recently approved by NICE for the prevention of migraine, and erenumab has been approved for the same circumstances as galcanezumab.

It comes in two strengths: only the 140mg dose has been approved, as the 70mg dose wasn’t effective enough.

Is erenumab any more effective than galcanezumab?

Read for free

Sign up to access everything.

Free trial


Already a member? Login to view this content.


Related content

"I regret not having joined earlier!!!"

Dr Maria Tome

See the full list of features within our NASGP membership plans